EMERGENT BIOSOLUTIONS INC. COMMON STOCK

Emergent BioSolutions Reports Financial Results For Second Quarter 2021

29 7 2021 15:05:01 提供 Nasdaq GlobeNewswire

Emergent BioSolutions to Resume Manufacturing Covid-19 Vaccine at Bayview Facility

29 7 2021 06:24:59 提供 Nasdaq GlobeNewswire

Reverse the Silence Campaign Casts a National Spotlight on Overdose Risks Associated with Opioid Use

26 7 2021 08:01:00 提供 Nasdaq GlobeNewswire

Emergent BioSolutions to Release Second Quarter 2021 Financial Results and Conduct a Conference Call on July 29, 2021

15 7 2021 05:30:00 提供 Nasdaq GlobeNewswire

COVID-19 Vaccine Drug Substance Manufactured by Emergent BioSolutions Authorized as Part of Johnson & Johnson’s Emergency Use Authorization

11 6 2021 15:35:24 提供 Nasdaq GlobeNewswire

Emergent BioSolutions Announces Positive Two-Year Persistence Data From Phase 2 Study Evaluating CHIKV VLP, the Company’s Chikungunya Virus Virus-Like Particle Vaccine Candidate

26 5 2021 05:30:00 提供 Nasdaq GlobeNewswire

Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 20, 2021 at 9:00am EDT

06 5 2021 05:30:00 提供 Nasdaq GlobeNewswire

Emergent BioSolutions to Participate in Investor Conferences

05 5 2021 15:05:02 提供 Nasdaq GlobeNewswire

Emergent BioSolutions Reports Financial Results for First Quarter 2021

29 4 2021 15:05:02 提供 Nasdaq GlobeNewswire

Statement on Issuance of Form FDA 483 at Emergent Bayview Facility

21 4 2021 11:46:42 提供 Nasdaq GlobeNewswire

Emergent BioSolutions to Release First Quarter 2021 Financial Results and Conduct a Conference Call on April 29, 2021

15 4 2021 05:30:00 提供 Nasdaq GlobeNewswire

Emergent BioSolutions On Track with Respect to COVID-19 Contractual Commitments; Receives Modified Task Order from the U.S. Department of Health & Human Services to Support the Opportunity for Further Expansion of Manufacturing Capacity for Johnson & Johnson’s COVID-19 Vaccine

04 4 2021 21:09:06 提供 Nasdaq GlobeNewswire

Emergent BioSolutions Announces Topline Data from NIAID Phase 3 ITAC Trial (INSIGHT-013) Evaluating Immunoglobulins as a Treatment for Hospitalized Patients with COVID-19

02 4 2021 07:00:00 提供 Nasdaq GlobeNewswire

Emergent BioSolutions to Participate in Investor Conferences

01 3 2021 05:30:00 提供 Nasdaq GlobeNewswire

Emergent BioSolutions Reports Financial Results for Fourth Quarter and Full Year 2020

18 2 2021 15:05:01 提供 Nasdaq GlobeNewswire

Emergent BioSolutions to Release Fourth Quarter and Full Year 2020 Financial Results and Conduct a Conference Call on February 18, 2021

04 2 2021 05:30:00 提供 Nasdaq GlobeNewswire

Emergent BioSolutions Announces 2021 Financial Guidance, Provides Preliminary 2020 Results

10 1 2021 13:00:00 提供 Nasdaq GlobeNewswire

Emergent BioSolutions to Participate in Investor Conferences

04 1 2021 05:30:00 提供 Nasdaq GlobeNewswire